Friday, 6 May 2016

SPARC Q4 net loss at Rs.95.80mn

The company has posted a net loss of Rs.699.90 million for the year ended March 31, 2016 compared with net loss of Rs.395.20 million for the year ended March 31, 2015.

Sun Pharma Advanced Research
Sun Pharma Advanced Research Company Ltd posted a net loss of Rs.95.80 million for the quarter ended March 31, 2016 compared with net loss Rs.94.00 million for the quarter ended March 31, 2015.

Total income increased from Rs.431.30 million for the quarter ended March 31, 2015 to Rs.434.90 million for the quarter ended March 31, 2016.

The company has posted a net loss of Rs.699.90 million for the year ended March 31, 2016 compared with net loss of Rs.395.20 million for the year ended March 31, 2015. Total income increased from Rs.1587.70 million for the year ended March 31, 2015 to Rs.1642.20 million for the year ended March 31, 2016.

Sun Pharma Advanced Research Company Ltd ended at Rs. 292.45, up by Rs. 2.3 or 0.79% from its previous closing of Rs. 290.15 on the BSE.

The scrip opened at Rs. 288.25 and touched a high and low of Rs. 295.2 and Rs. 288 respectively. A total of 226819(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 7164.01 crore.

The BSE group 'A' stock of face value Rs. 1 touched a 52 week high of Rs. 446.84 on 17-Jul-2015 and a 52 week low of Rs. 243.43 on 25-Feb-2016. Last one week high and low of the scrip stood at Rs. 304.9 and Rs. 285.85 respectively.

The promoters holding in the company stood at 67.4 % while Institutions and Non-Institutions held 8.57 % and 24.03 % respectively.

The stock traded above its 200 DMA.

No comments:

Post a Comment